OMNIBUS AMENDMENT TO STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMS (A3288) AND [***] AGREEMENTStandard Exclusive License Agreement • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Florida
This OMNIBUS AMENDMENT TO STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMS (A3288) AND [***] AGREEMENT (this “Amendment”) is made and entered into this 1st day of July, 2015 (the “Amendment Effective Date”) by and among University of Florida Research Foundation, Inc. (“UFRF”), a nonstock, nonprofit Florida corporation, the University of Florida Board of Trustees, a nonstock, nonprofit Florida corporation (“University”), Johns Hopkins University (“JHU”), a Maryland corporation and Applied Genetic Technologies Corporation, a Delaware corporation having a principal place of business at 11801 Research Drive, Suite D, Alachua, Florida 32615 (the “Licensee”). All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Joint Agreement (defined below) or the [***] (defined below) as applicable.
MANUFACTURING LICENSE AND TECHNOLOGY TRANSFER AGREEMENTConfidential Materials Omitted and Filed Separately With the Securities and Exchange Commission • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
This Manufacturing License and Technology Transfer Agreement (“Agreement”) is entered into as of July 1, 2015 (the “Execution Date”), and effective as of the Effective Date, by and between Applied Genetic Technologies Corporation, having a place of business at 11801 Research Drive, Suite D, Alachua, FL 32615 (“AGTC”) and Biogen MA Inc. (“LICENSEE”), having a place of business at 250 Binney Street, Cambridge, MA 02142. AGTC and LICENSEE are referred to collectively hereinafter as the “Parties” and individually as a “Party”.
COLLABORATION AND LICENSE AGREEMENT by and between BIOGEN MA INC. and APPLIED GENETIC TECHNOLOGIES CORPORATION July 1, 2015Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
This Collaboration and License Agreement (the “Agreement”) is entered into as of July 1, 2015 (the “Execution Date”), by and between Biogen MA Inc., a corporation organized and existing under the laws of the Commonwealth of Massachusetts and having a principal place of business at 250 Binney Street, Cambridge, MA 02142 (“Biogen”) and Applied Genetic Technologies Corporation, a corporation organized and existing under the laws of Delaware and having a principal place of business at 11801 Research Drive, Suite D, Alachua, FL 32615 (“AGTC”). Biogen and AGTC may each be referred to herein individually as a “Party” and collectively as the “Parties.”
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Massachusetts
This COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) dated as of July 1, 2015 (the “Execution Date”), is made by and between Applied Genetic Technologies Corporation, a Delaware corporation (the “Company”), and Biogen MA Inc., a Massachusetts corporation (the “Purchaser”).
FOUNDATION PARK LEASE AGREEMENTLease Agreement • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Florida
THIS LEASE is made as of the 10 day of APRIL, 2015, between ALACHUA FOUNDATION PARK HOLDING COMPANY, LLC, a Florida limited liability company, with its office at 3917 NW 97th Boulevard, Gainesville, Florida 32606, as Landlord, and APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation, whose address is 11801 Research Drive, Suite D, Alachua, Florida 32615, as Tenant.
SECOND AMENDMENT TO NON-EXCLUSIVE LICENSE AGREEMENT (CONVERTED TO EXCLUSIVE LICENSE AGREEMENT)Non-Exclusive License Agreement • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This Second Amendment to the Non-Exclusive License Agreement (this “Second Amendment”) is made and entered into this 29th day of June, 2015 (the “Second Amendment Effective Date”) by and between The UAB Research Foundation, an Alabama not-for-profit corporation having a principal place of business at 701 20th St. S., Birmingham, AL 35233 (“UABRF”) and Applied Genetic Technologies Corporation, a corporation existing and organized under the laws of the State of Delaware and having a principal place of business at 11801 Research Drive, Suite D, Alachua, Florida 32615 (the “Licensee”). Each of UABRF and the Licensee are referred to in this Amendment individually as a “Party” and collectively as the “Parties”. All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the License Agreement (defined below).
OMNIBUS AMENDMENT TO STANDARD EXCLUSIVE LICENSE AGREEMENT WITH KNOW HOW ([***] VECTORS LICENSE A12044) AND STANDARD NON-EXCLUSIVE LICENSE AGREEMENT ([***] VECTORS LICENSE A10571) AND STANDARD EXCLUSIVE LICENSE AGREEMENT WITH KNOW-HOW (VECTOR...Standard Exclusive License Agreement • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Florida
This OMNIBUS AMENDMENT TO STANDARD EXCLUSIVE LICENSE AGREEMENT WITH KNOW HOW ([***] VECTORS LICENSE A12044) AND STANDARD NON-EXCLUSIVE LICENSE AGREEMENT ([***] VECTORS LICENSE A10571) AND STANDARD EXCLUSIVE LICENSE AGREEMENT WITH KNOW-HOW (VECTOR TECHNOLOGY LICENSE A13332) (this “Amendment”) is made and entered into this 30th day of June, 2015 (the “Amendment Effective Date”) by and among University of Florida Research Foundation, Inc. (“UFRF”), a nonstock, nonprofit Florida corporation, and Applied Genetic Technologies Corporation, a Delaware corporation having a principal place of business at 11801 Research Drive, Suite D, Alachua, Florida 32615 (the “Licensee”). All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Exclusive License (defined below), the Non-Exclusive License (defined below), or the [***] License (defined below), as applicable.
